Impact BioMedical Correlations
| IBO Stock | USD 0.48 0.03 5.67% |
The current 90-days correlation between Impact BioMedical and Neurosense Therapeutics is -0.02 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Impact BioMedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Impact BioMedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Impact BioMedical Correlation With Market
Average diversification
The correlation between Impact BioMedical and DJI is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Impact BioMedical and DJI in the same portfolio, assuming nothing else is changed.
Moving against Impact Stock
| 0.4 | ALT | Altimmune | PairCorr |
| 0.32 | GSD | Devonian Health Group Split | PairCorr |
| 0.32 | SHPHF | Sihuan Pharmaceutical | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Impact Stock performing well and Impact BioMedical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Impact BioMedical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NRSN | 4.53 | 0.10 | 0.01 | 0.33 | 4.76 | 12.82 | 34.62 | |||
| AIM | 4.34 | (0.86) | 0.00 | (0.58) | 0.00 | 7.69 | 32.69 | |||
| BCLI | 3.69 | (0.19) | 0.00 | 0.54 | 0.00 | 9.09 | 24.01 | |||
| TCRT | 4.69 | 0.14 | 0.03 | 0.16 | 5.62 | 10.07 | 24.31 | |||
| MLEC | 9.29 | 0.24 | 0.03 | 0.20 | 11.04 | 15.63 | 152.55 | |||
| CYCN | 4.74 | (0.50) | 0.00 | (0.19) | 0.00 | 11.11 | 55.81 | |||
| QNRX | 7.22 | 0.25 | 0.01 | (0.13) | 8.49 | 18.69 | 77.47 | |||
| ADIL | 2.98 | (1.47) | 0.00 | (1.98) | 0.00 | 5.70 | 34.48 | |||
| XTLB | 5.07 | 0.13 | 0.01 | 0.31 | 5.66 | 8.25 | 69.50 | |||
| XBIO | 3.11 | (0.36) | 0.00 | 3.07 | 0.00 | 4.76 | 20.89 |
Impact BioMedical Corporate Executives
Elected by the shareholders, the Impact BioMedical's board of directors comprises two types of representatives: Impact BioMedical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Impact. The board's role is to monitor Impact BioMedical's management team and ensure that shareholders' interests are well served. Impact BioMedical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Impact BioMedical's outside directors are responsible for providing unbiased perspectives on the board's policies.